TUESDAY, March 1, 2022 (HealthDay News) — Fresh data shows that Pfizer’s COVID vaccine is far less powerful at preventing infection among children ages 5 to 11 than teens, a finding that could leave some parents of younger children worried. The vaccine — the only one authorized for that ageContinue Reading
TUESDAY, March 1, 2022 (HealthDay News) — Wanderlust has become a strong incentive for Americans to get COVID-19 vaccines, a new study finds. The bucket list beckons, and “many people consider travel an essential part of their lifestyle and a contributor to their sense of well-being,” said study lead authorContinue Reading
MONDAY, Feb. 28, 2022 (HealthDay News) — Settlements totaling $26 billion have been finalized between drugmaker Johnson & Johnson plus three major pharmaceutical distributors and state and local governments, over the companies’ role in America’s opioid crisis. The settlement plan — involving Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKessonContinue Reading
THURSDAY, Feb. 24, 2022 (HealthDay News) — Extreme heat from climate change is making it harder for people with mental illness and drug addiction to cope and adding to pressure on pandemic-stretched U.S. emergency rooms. During these severe summer temperature spikes, Americans with depression, anxiety, mood disorders and drug addictionContinue Reading
WEDNESDAY, Feb. 23, 2022 (HealthDay News) — Two doses of a new COVID-19 vaccine from Sanofi and GSK were 100% effective against severe disease and hospitalizations, the companies announced Wednesday. The vaccine was also 75% effective against moderate-to-severe disease and 58% effective against symptomatic disease in a Phase 3 clinicalContinue Reading
WEDNESDAY, Feb. 23, 2022 (HealthDay News) — Early on in the pandemic doctors observed that some children and teens infected with COVID-19 went on to develop a relatively rare, but potentially life-threatening, complication known as multisystem inflammatory syndrome in children (MIS-C). But new research out of the U.S. Centers forContinue Reading
WEDNESDAY, Feb. 23, 2022 (HealthDay News) — The U.S. Food and Drug Administration has issued another pointed warning about the dangers posed by tianeptine, an antidepressant that is not approved for any type of medical treatment in the United States. Topping the list of possible risks from taking the drug:Continue Reading
WEDNESDAY, Feb. 23, 2022 (HealthDay News) — Microdosing has become trendy in the era of drug legalization, with TV shows like “Nine Perfect Strangers” promoting the potential positives of regularly taking tiny amounts of psychedelics. But a new study finds that short-term microdosing of one hippy-era psychedelic, LSD, doesn’t appearContinue Reading
WEDNESDAY, Feb. 23, 2022 (HealthDay News) — Millions of American adults take a potentially deadly duo of prescription opioid painkillers and sedatives at the same time, researchers warn. The side effects of concurrent use of opioids and sedatives such as benzodiazepines (such as Xanax or Valium) may be even strongerContinue Reading
WEDNESDAY, Feb. 23, 2022 (HealthDay News) — A drug that has helped millions of men reinvigorate their sex lives seems to treat a rare, but often deadly, eating disorder in dogs, researchers say. The condition is called megaesophagus. It’s an enlargement of the esophagus and a loss of its abilityContinue Reading